Georgetown University Medical Center ( Site 0022) — Washington D.C., District of Columbia

Georgetown University Medical Center ( Site 0022) is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Georgetown University Medical Center ( Site 0022) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Urinary Bladder Cancer, Muscle-invasive, Bladder Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown University Medical Center ( Site 0022)?

Georgetown University Medical Center ( Site 0022) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown University Medical Center ( Site 0022) conducted?

Georgetown University Medical Center ( Site 0022) has 2 clinical trials on record, with 2 currently active. Their work covers Urinary Bladder Cancer, Muscle-invasive, Bladder Cancer.

Is Georgetown University Medical Center ( Site 0022) accredited by Crixeo Health?

Georgetown University Medical Center ( Site 0022) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetown University Medical Center ( Site 0022)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.